Comments
Lilly drug may slow memory loss in mild Alzheimer's
09.10.2012. | (Reuters) - Eli Lilly and Co said its experimental Alzheimer's drug led to a 34 percent reduction in memory decline for patients with mild symptoms over a period of 18 months, giving it potential ammunition to seek approval for the medicine that showed no benefit in more advanced stages of the disease.
......
